RHÖN-KLINIKUM AG / Capital Increase

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


THIS NOTICE IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION TO PERSONS IN
THE UNITED STATES

RHÖN-KLINIKUM AG resolves a capital increase by way of an issue of up to
34,552,000 no-par value shares at a subscription price of EUR 13.30 for
each new share, as well as the publication of the semi-annual financial
report as of 30 June 2009, prior to the originally scheduled publication
date

Bad Neustadt a.d. Saale, 19 July 2009 

I. Capital increase from authorised capital

Today the management board of RHÖN-KLINIKUM Aktiengesellschaft has
resolved, with the supervisory board's consent, a capital increase from
authorised capital.

According to this resolution, the company's share capital will be
increased, against cash contributions, from currently EUR259,200,000.00 by
up to EUR86,380,000.00 to an amount of up to EUR345,580,000.00 by way of an
issue of up to 34,552,000 no-par value shares, each with an arithmetical
pro rata amount of EUR2.50.

It is expected that the new shares will be offered for subscription to the
company's shareholders in the period from, and including, 22 July 2009
until, and including, 4 August 2009 at a subscription price of EUR13.30 for
each new share, and in a proportion of 3 to 1, i.e. three existing shares
entitle to subscribe for one new share. It is expected that trading of
subscription rights will be organised at the Frankfurt stock exchange from,
and including, 22 July 2009 until, and including, 31 July 2009. Subsequent
to the subscription period, a private placement of the unsubscribed new
shares with institutional investors by the syndicate banks, led by
Commerzbank AG and Morgan Stanley Bank AG, is planned.

For further details of this capital increase please see the offer for
subscription, which is expected to be published in the electronic Federal
Gazette and the Börsen-
Zeitung on 21 July 2009, as well as the German-language prospectus, which
is expected to be published on the company's webpage on 20 July 2009
subject to the approval of the German Federal Financial Supervisory
Authority (Bundesanstalt für Finanzdienstleistungsaufsicht - BaFin).


II. Publication of the semi-annual financial report (section 37w of the
German Securities Trading Act) as of 30 June 2009, prior to the originally
scheduled publication date
In connection with the capital increase from authorised capital as resolved
today, the management board of RHÖN-KLINIKUM Aktiengesellschaft has
resolved to publish the semi-annual financial report as of 30 June 2009
originally scheduled for 6 August 2009 prior to that date, on 30 June 2009.
It is expected that the semi-annual financial report as of 30 June 2009
will already be published on 20 July 2009.


These materials are not for distribution, directly or indirectly, in or
into the United States (including its territories and dependencies, any
State of the United States and the District of Columbia). These materials
do not constitute or form a part of any offer or solicitation to purchase
or subscribe for securities. The shares in RHÖN-KLINIKUM AG (the 'Shares')
mentioned herein may not be offered or sold in the United States absent
registration or an exemption from registration under the U.S. Securities
Act of 1933, as amended (the 'Securities Act'). The Shares have not been,
and will not be, registered under the Securities Act and will not be
offered or sold in the United States, except on the basis of applicable
exemptions from registration. There will be no public offering of
securities in the United States or anywhere outside of Germany. The public
offer in Germany will be made exclusively by means of and on the basis of a
German-language prospectus.



Contact:
Dr. Erik Hamann
Member of the Board of Management for Financing, IR, Controlling 
Tel. (09771) 65-1351  Tel.: (09771) 991736
E-mail: vfire@rhoen-klinikum-ag.com 

Dr. Irmgard Stippler
Member of the Board of Management for Communication/IT 
Tel.: (09771) 65-1321 Fax: (09771) 65-1820 
E-mail: kommunikation@rhoen-klinikum-ag.com




19.07.2009  Financial News transmitted by DGAP

 
Language:     English
Issuer:       RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Deutschland
Phone:        +49 (0)9771 - 65-0
Fax:          +49 (0)9771 - 97 467
E-mail:       rka@rhoen-klinikum-ag.com
Internet:     www.rhoen-klinikum-ag.com
ISIN:         DE0007042301
WKN:          704230
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), München;
              Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
 
End of News                                     DGAP News-Service